206 related articles for article (PubMed ID: 2670487)
1. Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions.
Schjoldager B; Mortensen PE; Myhre J; Christiansen J; Holst JJ
Dig Dis Sci; 1989 Sep; 34(9):1411-9. PubMed ID: 2670487
[TBL] [Abstract][Full Text] [Related]
2. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.
Wettergren A; Schjoldager B; Mortensen PE; Myhre J; Christiansen J; Holst JJ
Dig Dis Sci; 1993 Apr; 38(4):665-73. PubMed ID: 8462365
[TBL] [Abstract][Full Text] [Related]
3. Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man.
Schjoldager BT; Baldissera FG; Mortensen PE; Holst JJ; Christiansen J
Eur J Clin Invest; 1988 Oct; 18(5):499-503. PubMed ID: 3147901
[TBL] [Abstract][Full Text] [Related]
4. The effect of oxyntomodulin (glucagon-37) and glucagon on exocrine pancreatic secretion in the conscious rat.
Biedzinski TM; Bataille D; Devaux MA; Sarles H
Peptides; 1987; 8(6):967-72. PubMed ID: 3441447
[TBL] [Abstract][Full Text] [Related]
5. Effect of nifedipine on gastric emptying and gastrointestinal motility in man.
Santander R; Mena I; Gramisu M; Valenzuela JE
Dig Dis Sci; 1988 May; 33(5):535-9. PubMed ID: 3282847
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men.
Schirra J; Kuwert P; Wank U; Leicht P; Arnold R; Göke B; Katschinski M
Proc Assoc Am Physicians; 1997 Jan; 109(1):84-97. PubMed ID: 9010920
[TBL] [Abstract][Full Text] [Related]
7. Oxyntomodulin and glicentin are potent inhibitors of the fed motility pattern in small intestine.
Pellissier S; Sasaki K; Le-Nguyen D; Bataille D; Jarrousse C
Neurogastroenterol Motil; 2004 Aug; 16(4):455-63. PubMed ID: 15306001
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin and oxyntomodulin-(30-37) potentiate PYY regulation of gastric acid and somatostatin secretions.
Bado A; Cloarec D; Moizo L; Laigneau JP; Bataille D; Lewin MJ
Am J Physiol; 1993 Jul; 265(1 Pt 1):G113-7. PubMed ID: 8101697
[TBL] [Abstract][Full Text] [Related]
9. The biological significance of "enteroglucagon." Present status.
Bataille D; Jarrousse C; Kervran A; Depigny C; Dubrasquet M
Peptides; 1986; 7 Suppl 1():37-42. PubMed ID: 3529053
[TBL] [Abstract][Full Text] [Related]
10. The role of gastrointestinal hormones in the control of postprandial and interdigestive gastrointestinal function.
Go VL; Miller LJ
Scand J Gastroenterol Suppl; 1983; 82():135-42. PubMed ID: 6356315
[TBL] [Abstract][Full Text] [Related]
11. Oxyntomodulin (glucagon-37) and its C-terminal octapeptide inhibit gastric acid secretion.
Jarrousse C; Audousset-Puech MP; Dubrasquet M; Niel H; Martinez J; Bataille D
FEBS Lett; 1985 Aug; 188(1):81-4. PubMed ID: 4018272
[TBL] [Abstract][Full Text] [Related]
12. Is glucagon-like peptide 1 an incretin hormone?
Nauck MA
Diabetologia; 1999 Mar; 42(3):373-9. PubMed ID: 10096792
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow.
Wettergren A; Wøjdemann M; Holst JJ
Am J Physiol; 1998 Nov; 275(5):G984-92. PubMed ID: 9815028
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of galanin on postprandial gastrointestinal motility and gut hormone release in humans.
Bauer FE; Zintel A; Kenny MJ; Calder D; Ghatei MA; Bloom SR
Gastroenterology; 1989 Aug; 97(2):260-4. PubMed ID: 2472997
[TBL] [Abstract][Full Text] [Related]
15. Novel approach to quantify duodenogastric reflux in healthy volunteers and in patients with type I gastric ulcer.
Müller-Lissner SA; Fimmel CJ; Sonnenberg A; Will N; Müller-Duysing W; Heinzel F; Müller R; Blum AL
Gut; 1983 Jun; 24(6):510-8. PubMed ID: 6852631
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of the C-terminal octapeptide of oxyntomodulin on pentagastrin-stimulated gastric acid secretion in man.
Veyrac M; Ribard D; Daures JP; Mion H; Lequellec A; Martinez J; Bataille D; Michel H
Scand J Gastroenterol; 1989 Dec; 24(10):1238-42. PubMed ID: 2690315
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans.
Meier JJ; Nauck MA; Pott A; Heinze K; Goetze O; Bulut K; Schmidt WE; Gallwitz B; Holst JJ
Gastroenterology; 2006 Jan; 130(1):44-54. PubMed ID: 16401467
[TBL] [Abstract][Full Text] [Related]
18. Activity of oxyntomodulin on gastric acid secretion induced by histamine or a meal in the rat.
Jarrousse C; Carles-Bonnet C; Niel H; Bataille D
Peptides; 1994; 15(8):1415-20. PubMed ID: 7700845
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of acute mental stress on interdigestive secretion of gastric acid, pancreatic enzymes, and gastroduodenal motility.
Holtmann G; Singer MV; Kriebel R; Stäcker KH; Goebell H
Dig Dis Sci; 1989 Nov; 34(11):1701-7. PubMed ID: 2582983
[TBL] [Abstract][Full Text] [Related]
20. GLP-1 regulates gastroduodenal motility involving cholinergic pathways.
Schirra J; Nicolaus M; Woerle HJ; Struckmeier C; Katschinski M; Göke B
Neurogastroenterol Motil; 2009 Jun; 21(6):609-18, e21-2. PubMed ID: 19220754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
